As of 2026-03-29, 云南同丰医药's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 4.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 云南同丰医药's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
云南同丰医药's Mention Rate is 0.00%, lower than 0.6% of competitors
云南同丰医药's First Mention is 0.00%, lower than 0.9% of competitors
云南同丰医药's Preferred Rate is 0.00%, lower than 100.0% of competitors
云南同丰医药's Positive Rate is 0.00%, lower than 8.9% of competitors
云南同丰医药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 华华北制药 | 10.2% | 0% | 0% | 2.04% | 10.2% | View Details |
| 齐齐鲁制药 | 8.16% | 0% | 0% | 6.12% | 0% | View Details |
| 汤汤臣倍健 | 0% | 0% | 0% | 0% | 0% | View Details |
| SSwisse斯维诗 | 0% | 0% | 0% | 0% | 0% | View Details |
| 金金达威 | 0% | 0% | 0% | 0% | 0% | View Details |
| 邵邵阳神农中药科技发展有限公司 | 0% | 0% | 0% | 0% | 0% | View Details |
| 云云南同丰医药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
